&w=3840&q=100)
'A gift of life': How a cancer drug doubles the survival rate
A drug called pembrolizumab, sold under the brand name Keytruda, kept head and neck cancers at bay for five years compared to 30 months with standard care. Image for Representation. Pixabay
Hundreds of thousands of patients with advanced head and neck cancer could live years longer without the disease, thanks to a breakthrough immunotherapy drug, a new clinical trial suggests.
The study revealed that the drug called pembrolizumab, sold under the brand name Keytruda, kept head and neck cancers at bay for five years compared to 30 months with standard care.
When added to current therapies, it could potentially double the time patients live without a recurrence, making it one of the biggest breakthroughs in two decades.
STORY CONTINUES BELOW THIS AD
Kevin Harrington, professor of biological cancer therapies at the Institute of Cancer Research in London and lead researcher of the trial, described the development as game-changing.
'This could change the world for these patients,' he told the BBC. 'It significantly decreases the chance of cancer spreading around the body, at which point it's incredibly difficult to treat.'
So, how exactly does Pembrolizumab work? And what did the trial reveal? We break it down.
'A gift of life'
For Laura Marston, a 45-year-old from Derbyshire, the immunotherapy drug pembrolizumab has been nothing short of 'a gift of life'.
Back in 2019, Laura noticed an ulcer on her tongue that just wouldn't heal. Tests revealed it was cancer, and doctors gave her only a 30 per cent chance of long-term survival.
'I was 39 and I was devastated,' she told the BBC.
The road ahead was tough. She had to undergo major surgery to remove her tongue and the lymph nodes in her neck. After that came the even harder part, learning how to talk and eat again.
'My prognosis was quite dire,' she recalled. Surgeons had to use muscle from her left arm to rebuild the inside of her mouth. It changed her life in every way.
But amid the struggle, there was hope.
Laura joined an international clinical trial testing a new approach to treatment, one that used pembrolizumab not just after surgery, but also before it.
STORY CONTINUES BELOW THIS AD
Patients who received pembrolizumab lived cancer-free for twice as long, five years on average, compared to just 2.5 years with standard treatment. Representational Image/Pixabay
The clinical trial, led by researchers at Washington University School of Medicine and involving scientists from the Institute of Cancer Research in London, enrolled over 700 patients across 24 countries.
The trial, which is being presented at the American Society of Clinical Oncology (Asco), the world's largest cancer conference, showed that the patients who received pembrolizumab lived cancer-free for twice as long, five years on average, compared to just 2.5 years with standard treatment.
The drug also cut the chances of the cancer returning elsewhere in the body by 10 per cent after three years.
'Immunotherapy has been amazingly beneficial for patients whose cancer has come back or spread,' said Harrington, who co-led the study, told The Guardian. 'But until now, it hadn't shown this kind of success in people being treated for the first time.'
Today, six years after her diagnosis, Laura is working full-time and doing well.
'It's been phenomenal for me,' she said. 'Because I'm here, able to talk to you. Just having this amazing immunotherapy has given me my life back again.'
STORY CONTINUES BELOW THIS AD
How does the drug work?
Unlike traditional cancer treatments like chemotherapy, which attack the tumour directly, immunotherapy works by boosting the body's own defences. It helps the immune system recognise cancer cells and destroy them.
In this trial, researchers found that the timing of the drug was key. Patients were given pembrolizumab before surgery, allowing their immune systems to get familiar and kill the cancer if it ever comes back.
'We give the immune system the chance to have a good look at the tumour to generate anti-tumour immunity,' explained Harrington told BBC. 'Then, after removal of the tumour, we continue to amplify that immune response by giving the drug continually for up to a year.'
The treatment worked especially well for people with high levels of a protein called PD-L1, which acts as a marker for how active the immune system might be. But even patients without high PD-L1 levels saw clear benefits. The risk of cancer returning or spreading dropped significantly across the board.
'This research shows that immunotherapy could change the world for these patients,' Harrington said. 'It significantly decreases the chance of cancer spreading around the body, and that's when it becomes incredibly difficult to treat.'
STORY CONTINUES BELOW THIS AD
With input from agencies
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
First Post
6 hours ago
- First Post
Rare pneumonia-like illness kills 3 in New York City: What is Legionnaires' disease? Is it deadly?
Three people have died and 67 others have been diagnosed with Legionnaires' disease in New York City in recent weeks. The illness, a type of pneumonia caused by Legionella bacteria, mainly affects people over 50, smokers, and those with chronic lung issues or weakened immunity read more Three people have died and 67 others have been diagnosed with Legionnaires' disease in New York City's Harlem in recent weeks. Those at greater risk include people over the age of 50, smokers, and individuals with weakened immune systems or long-term breathing problems. Health authorities have advised them to take extra care. ALSO READ | Ditch that soda and noodles. The lung cancer link to ultra-processed foods Officials say the outbreak in Central Harlem is connected to cooling towers. These are large units that use water and fans to help cool buildings. STORY CONTINUES BELOW THIS AD But what exactly is this pneumonia-like illness? What symptoms should people look out for, and how is it treated? Let's take a look: What is Legionnaires' disease? Legionnaires' disease is a form of pneumonia caused by Legionella bacteria. These bacteria grow in warm water and can spread through building water systems. Common sources include showerheads, hot tubs and cooling towers. People usually catch the illness by breathing in small droplets of contaminated water. Hospital patients can also get infected through tainted water or ice, and babies may be exposed during water births, according to health officials. The disease does not spread from person to person. It mainly affects the lungs but can also harm the brain and digestive system. In some cases, it can be life-threatening. Stomach pain is one of the symptoms. Pixabay/Representational Image Although not very common, Legionnaires' disease has been reported more often in recent years. According to the US Centers for Disease Control and Prevention, the number of cases has gone up nearly nine times since 2000. In the Harlem outbreak, health officials have linked the source to cooling towers. So far, 11 towers have tested positive for the bacteria. These towers help cool large systems like central air conditioning and refrigeration. Authorities have assured residents in the affected areas that their tap water is safe. They can continue to shower, bathe, cook and use air conditioners at home. STORY CONTINUES BELOW THIS AD Symptoms of Legionnaires' disease Legionnaires' disease usually develops two to 14 days after contact with the bacteria and causes symptoms similar to pneumonia. Common symptoms include: Fever Muscle aches Cough (often dry) Shortness of breath Headache Nausea Diarrhoea Stomach pain Confusion Coughing up blood While it mostly affects the lungs, the infection can also spread to wounds and other parts of the body, including the heart. ALSO READ | Is it safe to boil water more than once? Can it be treated? Yes. Legionnaires' disease is treated with antibiotics. These may be given through a drip or as tablets, depending on the condition of the patient, according to Cleveland Clinic. If breathing becomes difficult, doctors may provide oxygen support. Most people need hospital care while being treated. 'Legionnaires' disease can be effectively treated if diagnosed early, but New Yorkers at higher risk, like adults aged 50 and older and those who smoke or have chronic lung conditions, should be especially mindful of their symptoms and seek care as soon as symptoms begin,' said acting Health Commissioner Dr Michelle Morse was quoted as saying by The New York Post. With early treatment, most people recover fully, though it may take a few weeks to feel completely well again. Officials say the outbreak in New York City's Central Harlem is connected to cooling towers. Reuters/File Photo How can Legionnaires' disease be prevented? According to the World Health Organization (Who), those in charge of maintaining buildings and water systems can help prevent Legionnaires' disease by limiting the growth of Legionella bacteria. This includes regularly cleaning and disinfecting cooling towers, keeping the right level of chlorine in spa pools and flushing unused taps at least once a week. There are also precautions people can take at home. Health officials in New York state recommend draining garden hoses, following cleaning and replacement instructions for water filters, checking chlorine levels in pools and hot tubs often and flushing hot water heaters twice a year. STORY CONTINUES BELOW THIS AD Is it deadly? Legionnaires' disease is a serious illness, but with the right treatment, most people recover. Lung infections caused by Legionella are fatal in about five to 10 per cent of treated cases. Without treatment, the risk of death rises sharply, with fatality rates ranging from 30 to 80 per cent. With inputs from agencies
Indian Express
17 hours ago
- Indian Express
China reports over 7,000 Chikungunya cases, US CDC issues travel warning: Know what is Chikungunya, its symptoms
More than 7,000 Chikungunya cases have been reported across China's Guangdong province since July, triggering the Chinese administration to take measures similar to those taken during the COVID-19 pandemic, BBC reported. Chinese health officials have said that the worst affected city in the Guangdong province is the southern city of Foshan with most cases. Some of the measures for those affected by the mosquito-borne virus in Foshan include that patients remain in hospital, their beds will be protected with mosquito nets. Patients of Chikungunya cannot leave the hospital until they test negative or after a week-long stay. The Chikungunya virus is, however, a rarity in China and the outbreaks are more common in South and South East Asia and parts of Africa. The US Centers for Disease Control and Prevention (CDC) issued a warning for travellers due to the mosquito-borne virus being transmitted in parts of southeast China. The Chikungunya disease is caused by the Chikungunya virus which spreads through infected female mosquitoes, most commonly the subspecies Aedes aegypti and Aedes albopictus, which are the same type of mosquitoes that spread Zika and Dengue virus. Chikungunya outbreaks have occurred in countries in Africa, Americas, Asia, Europe, the Caribbean, and Indian and Pacific Oceans. In a troublesome update by the US CDC, there is no specific treatment for chikungunya. When a mosquito feeds on an infected person, it ingests the virus and can transmit it to other humans. The onset of the virus is usually four to eight days after the infected mosquito bites the person. People with risk of more severe disease include newborns infected around the time of birth, older adults (65 years or older), and people with medical conditions such as diabetes or heart disease. Those infected with Chikungunya virus typically show symptoms 3-7 days after a bite by an infected mosquito. The most common symptoms are fever and joint pain. According to WHO, Chikungunya virus can also cause muscle pain, headaches, nausea and rashes. The CDC says most people get better within a week's time but some can have severe joint pain for months to years following acute illness.
Time of India
a day ago
- Time of India
CDC issues level 2 travel alert for China as chikungunya spreads — Symptoms US travelers should watch for
Americans planning a trip to China are being urged to stay alert. The U.S. Centers for Disease Control and Prevention (CDC) has issued a Level 2 travel alert following a major outbreak of the chikungunya virus. The warning comes after over 7,000 cases were reported in Guangdong province, according to the BBC. In Foshan, one of the hardest-hit cities, patients are being hospitalized until they test negative. Hospitals are using mosquito nets on beds, something not seen since the early COVID-19 days. How the virus spreads Chikungunya is a mosquito-borne virus. It spreads through the bite of an infected female mosquito—usually Aedes aegypti or Aedes albopictus. These mosquitoes also transmit dengue and Zika. They bite mostly during daylight and lay eggs in still water, like puddles, buckets, or plant pots. When a mosquito bites someone infected with chikungunya, it picks up the virus. Over the next few days, the virus multiplies inside the mosquito. Once it reaches the mosquito's saliva, it can pass on the virus to the next person it bites. That person can then pass it on to more mosquitoes, creating a cycle. Symptoms to watch for As per the World Health Organization, Symptoms usually appear 4–8 days after the bite (but can show up as early as 2 days or as late as 12). The illness often begins suddenly. Key signs include: High fever Intense joint pain (often severe and long-lasting) Swollen joints Muscle pain Headache Nausea Fatigue Rash Symptoms can be confused with other viruses like dengue and Zika. Without the telltale joint pain, mild cases may go unnoticed. Patients mostly recover fully from the infection; however, occasional cases of eye, heart, and neurological complications have been reported with CHIKV infections. Who is at risk? Those at highest risk for severe chikungunya infection include people at the extremes of age. Newborns are particularly vulnerable, especially if they are infected during delivery from a mother who has the virus, or if they are bitten by an infected mosquito within the first few weeks of life. Older adults, particularly those with underlying medical conditions such as heart disease, diabetes, or weak immunity, are also more likely to experience complications. How to protect yourself? If you are travelling to China or places nearby, it is advised to follow some precautions to protect yourself Apply EPA-registered insect repellents containing DEET, picaridin, or oil of lemon eucalyptus to exposed skin to prevent bites. Covering your skin reduces the chances of mosquitoes landing on and biting you. Mosquitoes breed in stagnant water, so steer clear of places with puddles, open containers, or clogged drains. Aedes mosquitoes that spread chikungunya bite mostly during the day, so limit outdoor activity during daylight hours. Proper ventilation and screened windows keep mosquitoes out and help create a safe, bite-free environment indoors.
